PolarityBio
Pre-clinicalPolarityBio is a clinical-stage biotechnology company advancing regenerative biologics for chronic wound healing. Its lead investigational therapy, SkinTE®, is an autologous heterogeneous skin multicellular therapy being evaluated in a Phase III pivotal study for Wagner Grade 1 diabetic foot ulcers,
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $4.2M
About
PolarityBio is a clinical-stage biotechnology company advancing regenerative biologics for chronic wound healing. Its lead investigational therapy, SkinTE®, is an autologous heterogeneous skin multicellular therapy being evaluated in a Phase III pivotal study for Wagner Grade 1 diabetic foot ulcers,
BiologicsAntibodies
Funding History
1Total raised:$4.2M
Seed$4.2MNov 15, 2022